The global genomic data set for real world evidence (RWE) applications market is set for significant growth, reaching USD 1,704.60 million by 2032 from USD 526.10 million in 2024, expanding at a remarkable CAGR of 15.2% during the forecast period. Increasing adoption of precision medicine, rising demand for genomic databases, and integration of big data analytics are expected to propel market...
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek